WTA
CBAY

Washington Trust Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Washington Trust Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-153
Closed -$3.61K – 683
2023
Q4 		$3.61K Hold
153
– – ﹤0.01% 604
2023
Q3 		$2.28K Buy
+153
New +$2.03K ﹤0.01% 634

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Washington Trust Advisors's CBAY Position: Q1 2024 in Review

Washington Trust Advisors sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 153 shares — an estimated $3.61K sold.

Washington Trust Advisors first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $3.61K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Washington Trust Advisors reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Washington Trust Advisors sold 153 Cymabay Therapeutics shares in Q1 2024, an estimated $3.61K.
  • Washington Trust Advisors first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Washington Trust Advisors's Cymabay Therapeutics position peaked at $3.61K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Washington Trust Advisors's 13F filing for Q1 2024, filed 7 May 2024.